Smart for Life (SMFL) Competitors $0.0051 +0.00 (+96.15%) As of 01:44 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SMFL vs. NCNA, NAVB, SYRS, VRPX, SCPS, EVLO, CMRA, GNCAQ, GNCA, and ARDSShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include NuCana (NCNA), Navidea Biopharmaceuticals (NAVB), Syros Pharmaceuticals (SYRS), Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), and Aridis Pharmaceuticals (ARDS). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Its Competitors NuCana Navidea Biopharmaceuticals Syros Pharmaceuticals Virpax Pharmaceuticals Scopus BioPharma Evelo Biosciences Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals NuCana (NASDAQ:NCNA) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability. Which has better earnings & valuation, NCNA or SMFL? Smart for Life has higher revenue and earnings than NuCana. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuCanaN/AN/A-$24.28M-$1.40 thousand0.00Smart for Life$11.11M0.00-$22.68MN/AN/A Is NCNA or SMFL more profitable? Smart for Life's return on equity of 0.00% beat NuCana's return on equity.Company Net Margins Return on Equity Return on Assets NuCanaN/A -319.85% -88.55% Smart for Life N/A N/A N/A Does the media refer more to NCNA or SMFL? In the previous week, NuCana had 2 more articles in the media than Smart for Life. MarketBeat recorded 2 mentions for NuCana and 0 mentions for Smart for Life. NuCana's average media sentiment score of 0.50 beat Smart for Life's score of 0.00 indicating that NuCana is being referred to more favorably in the media. Company Overall Sentiment NuCana Positive Smart for Life Neutral Which has more risk and volatility, NCNA or SMFL? NuCana has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Smart for Life has a beta of 17.05, meaning that its stock price is 1,605% more volatile than the S&P 500. Do analysts recommend NCNA or SMFL? NuCana currently has a consensus target price of $5,000.00, indicating a potential upside of 140,349.44%. Given NuCana's stronger consensus rating and higher probable upside, analysts clearly believe NuCana is more favorable than Smart for Life.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NuCana 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Smart for Life 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in NCNA or SMFL? 44.0% of NuCana shares are owned by institutional investors. Comparatively, 28.4% of Smart for Life shares are owned by institutional investors. 31.2% of NuCana shares are owned by insiders. Comparatively, 31.7% of Smart for Life shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryNuCana and Smart for Life tied by winning 6 of the 12 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$36K$3.51B$5.72B$9.81BDividend YieldN/AN/A4.54%4.06%P/E RatioN/A8.8822.2123.97Price / Sales0.0062.40450.51113.03Price / CashN/A5.6237.3459.16Price / Book0.001.158.886.24Net Income-$22.68M$17.44M$3.26B$265.56M7 Day PerformanceN/A8.50%1.73%0.90%1 Month PerformanceN/A7.31%3.54%1.88%1 Year PerformanceN/A-28.22%28.63%20.09% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.01+96.2%N/A-99.7%$36K$11.11M0.00110NCNANuCana3.3658 of 5 stars$4.67-0.8%$5,000.00+106,966.4%-99.4%$139KN/A0.0030News CoverageUpcoming EarningsAnalyst UpgradeNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-50.0%$50K$8.13K0.0010SYRSSyros Pharmaceuticals4.3857 of 5 stars$0.00flat$3.33+302,930.3%-99.9%$30K$386K0.00120Short Interest ↓VRPXVirpax PharmaceuticalsN/A$0.01flatN/A-99.9%$14KN/A0.007SCPSScopus BioPharmaN/A$0.00flatN/AN/A$13KN/A0.009High Trading VolumeEVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9KN/A0.00120CMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070ARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$5KN/A0.0030High Trading Volume Related Companies and Tools Related Companies NuCana Competitors Navidea Biopharmaceuticals Competitors Syros Pharmaceuticals Competitors Virpax Pharmaceuticals Competitors Scopus BioPharma Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Genocea Biosciences Competitors Genocea Biosciences Competitors Aridis Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access